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Human placenta has a  diversity of functions directed at maintaining the fetal 
environment  (endocrine  functions,  fetomaternal  nutritive,  and  gaseous  ex- 
change, etc.) (1). The placenta is a  complex organ composed of different types 
of trophoblasts and a  variety of other fetal tissues such as stroma, endothelium, 
and blood 'elements.  Furthermore,  the junctional area of the human placenta 
with the  uterus  comprises  an admixture of fetal and maternally derived cells. 
Numerous attempts have been made to identify and characterize placental cells 
in single cell suspension or in primary culture (2-6), but until now no satisfactory 
method has been developed. 
As the fetus is genetically foreign to the maternal organism, one unique and 
important function of placenta may be to serve as an immunological barrier to 
maternal alloreactivity (7).  One  persistent  suggestion is  that trophoblast  lacks 
HLA-A,B,C antigens, and both immunohistological and biochemical data exist 
supporting this suggestion (8-10).  However, the presence  of HLA-A,B,C anti- 
gens on early nonvillous trophoblasts has also been reported (1 1).  Quantitative 
data on neither expression nor regulatory mechanisms of HLA-A,B,C antigens 
for individual placental trophoblasts or other cells is available. 
In this paper, we establish a  method for isolating specific placental cell popu- 
lations and define the basic characteristics of human placental cells in suspension 
using  coordinate  two-color  and  light-scatter  fluorescence-activated cell  sorter 
(FACS) 1 analysis and sorting. We present data showing at least five populations 
of placental cells and describe their cell surface antigens, size, frequency, genetic 
origin, tissue-specific enzymes, and morphological appearances. The major pop- 
ulation is clearly identified as cytotrophoblasts. 
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The  apparent  lack  of HLA-A,B,C  antigens  and  /32-microglobulin  (~32m) on 
placental  cytotrophoblasts  prompted  us  to  analyze  the  underlying  molecular 
mechanisms.  The expression  of HLA-A,B,C antigens  on  the  cell  surface could 
be controlled by the rate of transcription of the gene for either of the two chains 
or at any of a  number of posttranscriptional  steps, including  mRNA processing, 
degradation,  or translation.  It is also possible that the  HLA-A,B,C heavy chain 
and/32m  proteins are synthesized  normally and  that some other cellular defect 
prevents the  proper assembly and  transport  of the  heterodimeric  molecules to 
the cell surface. In order to distinguish among these possibilities, we used HLA- 
A,B,C and/32m  cDNA probes in  Northern  blot hybridizations,  and found that 
human cytotrophoblasts have extremely small amounts of HLA-A,B,C mRNA, 
but ~ 10% of the levels of/32m mRNA found in lymphoid cells. 
Materials of Methods 
Isolation  of Placental Cells.  Placentas were obtained immediately after uncomplicated 
deliveries or Caesarian sections at term.  Chorionic membrane and umbilical cord were 
stripped, and the material side of the placenta was scraped with a scalpel to remove the 
bulk of decidual cells.  Placentas were then minced with scissors and washed extensively 
with RPMI-1640 (Irvine Scientific, Santa Ana, CA) to reduce blood contamination. The 
crudely dissected placental villi  were cut into pieces of about  1 mm  ~, washed through 
gauze to remove contaminating blood  cells,  and  then  pelleted  at  ~300 g  for  10  min. 
Pellets were resuspended in 0.5% trypsin, 0.2% EDTA solution at ~2.5 ml of solution for 
each gram of tissue, and agitated gently at 37°C for 30 min. Proteolysis was stopped by 
addition of 3-4 volumes of 5% newborn calf serum (NCS) in RPMI-1640, and centrifuga- 
tion at 500 g for 10 min at room temperature. The clear supernatant fluid was discarded. 
The loose pellet was resuspended  in  an equal  volume of 0.03%  DNase  in  phosphate- 
buffered saline and digested at 37°C  for 30 min in order to remove viscous DNA-like 
material associated with the tissue. Free single cells were separated from undigested tissue 
fragments by passage through a double layer of gauze. After the remaining erythrocytes 
were lysed with 0.165 M NH4CI solution on ice for 5 min, cells were washed, resuspended 
in  5%  NCS  RPMI-1640, and counted.  Viability was determined by ethidium bromide- 
acridine orange staining (12), and was always >90%. Usually 1-2 ×  10  ~ cells/g wet tissue 
were recovered from full-term placentas. Before we adapted this method, various concen- 
trations of collagenase and  trypsin  were  used  with  yields,  viability, and  HLA antigen 
densities inferior to those of the method described. 
Monoclonal  Antibodies  and Avidin-Texas  Red for Immunofluorescence  Staining.  Mono- 
clonal antibodies  MB40.5  (13),  W6/32  (14),  which  identify framework components of 
HLA-A,B,C heavy chain, PA2.1 (15), which reacts specifically with HLA-A2 antigen, and 
BBM. 1 (16), which reacts with/32m whether in association with HLA-A,B,C heavy chain 
or not, were kindly provided by Dr.  P.  Parham,  Stanford University. Monoclonal anti- 
bodies, anti-fl2m (L368, which reacts when associated with HLA-A,B,C) (17),  anti-HLA- 
DR (17), -HLel, a pan-leucocyte antibody (18),  and -LeuM 1, a  monocyte/macrophage 
lineage antibody (19) were provided by Becton-Dickinson Monoclonal Center, Mountain 
View,  CA.  Anti-Trop-1  and  anti-Trop-2,  which  are  monoclonal antibodies  specific to 
human trophoblast, were previously produced in our laboratory (20). Titrations with both 
first- and  second-step reagents  were  carried  out  on  known  target cells and  saturating 
concentrations were used in  this study.  Biotin-coupled indirect fluorescence and direct 
fluorescence labeling procedures have been described (21).  Texas red-labeled avidin was 
prepared as described previously (21).  All reagents were stored at 4 °C with 0.1% sodium 
azide and centrifuged immediately before use. 
Immunofluorescence  Staining.  Single cell suspensions were stained in  50-150  ~1 total 
volume in microtiter wells.  For two-color staining,  10  ~ placental cells were incubated in a KAWATA  ET  AL.  635 
mixture of a first antibody conjugated with fluorescein and a second antibody conjugated 
with biotin for 20  min on ice.  After 2  washes, avidin conjugated with TR was added, 
incubated on ice for 20 min, and washed twice. Propidium iodide (PI) was added (50 ~1 
per well at  1 t~g/ml) to label dead cells (22).  Staining medium was the same as that used 
for isolation of placental cells. 
Two-color  immunofluorescence  analysis  and  sorting  was  carried  out  as  described 
elsewhere (22).  We always confirmed that a pair of antibodies or reagents did not inhibit 
the staining of each other. Briefly, several improved analytical techniques were used. Dead 
cells stained  with  PI were excluded by gating on the extremely high red  fluorescence 
signal,  since  large dead  cells cannot be excluded  from fluorescence analysis simply by 
gating out of cells with low forward light scatter signals. For "off  line" analysis, we collected 
correlated two fluorescent and forward light scatter measurements "list mode" on a VAX 
11/780 computer on 20,000 PI-excluding (live) cells. 
Y-Chromatin Detection.  For fluorescent microscopic analysis, the cells in each subpop- 
ulation were sorted directly into wells on microscope slides and then centrifuged, fixed, 
and stained with quinacrine as described previously (23). 
Specific identification of placental alkaline phosphatase (PAP) or liver alkaline phospha- 
tase (LAP) used immunoprecipitation followed by an enzymatic assay (24).  Briefly, cells 
are lysed, specific antibody is added, and the complex is precipitated with Staphylococcus 
A.  Alkaline  phosphatase  activity  in  the  supernatant  is  determined  before  and  after 
precipitation of PAP or LAP.  The difference represents the percentage of the specific 
isoenzyme in the total activity. Phosphatase activity is measured by release ofp-nitrophenol 
(by spectrophotometry at 405  nm) from p-nitrophenyl phosphate at 2 mg/ml in mono- 
ethanolamine buffer (pH 11.2) at 37°C. 
Morphological examination was carried out with smears prepared from sorted cells. 
Smears were fixed with methanol and stained with Giemsa. 
Cell Lines.  LCL-721, a  human lymphoid cell line (25),  which expresses HLA-A,B,C 
and fl2m to a similar degree as normal peripheral lymphocytes; Daudi, a human Burkitt 
lymphoma cell line, which lacks surface HLA-A,B,C and fl2m; and F9, a mouse undiffer- 
entiated teratocarcinoma cell line that lacks H-2 and fl2m protein and mRNA (26). 
cDNA Probes.  An HLA-B7 cDNA clone that cross-hybridizes with HLA-A,B,C genes 
and  mRNA  and  contains  a  1400-bp  insert  (27)  was  generously  provided  by  Dr.  S. 
Weissman (Dept. Human Genetics, Yale Univ.). A human fl2m cDNA clone containing 
328 bp of protein coding sequence and 217 bp of 3'untranslated region (28) was the kind 
gift of Dr. K. hakura (City of Hope Hospital, Duarte,  CA). For both clones the largest 
Cfo I fragment (containing primarily cDNA insert plus 337 bp of pBR 322) was isolated 
and labeled with S~p by nick translation to a specific activity of 2 ×  108 cpm/#g. 
RNA Gels and Hybridization.  RNA was extracted from frozen cell pellets by homoge- 
nization in the presence of 4 M guanidine thiocyanate, centrifugation through a cushion 
of 5.7 M cesium chloride, and ethanol precipitation as described by Chirgwin et al. (29). 
The amount of RNA was determined by measuring the A260.  120 #g of total RNA was 
obtained from 4 x  107 sorted placental cytotrophoblast cells.  12 #g of each RNA sample 
in 50% formamide, 2.2 M formaldehyde, and 1 × MOPS buffer was denatured by heating 
for 5  min at 70°C,  quick chilled, and electrophoresed in  1.5%  agarose gels containing 
2.2  M  formaldehyde and  6.25  #g/ml  ethidium  bromide  in  1  ×  MOPS  buffer.  RNA 
separated by electrophoresis was subsequently transferred to nitrocellulose filters accord- 
ing to the procedure of Thomas (30). Blots were hybridized to [32P]-labeled  HLA-A,B,C 
or 132m probes for 18 h at 42°C in 40% formamide, 4 x  SSC,  1 ×  Denhardt's solution, 
20  mM Tris pH 7.6,  0.1%  SDS,  100  #g/ml denatured  herring sperm DNA,  and 50% 
dextran sulfate. The filters were then washed at room temperature with four changes of 
2 x  SSC and 0.1% SDS for 20 min each, followed by three washes at 55°C for 1 h each 
with 0.1  x  SSC and 0.1% SDS. (1  x  SSC =  0.15 M NaC1, 0.015 M Na citrate). The filters 
were then dried and exposed to XAR-5 film (Kodak) at -70°C overnight. The intensities 
of the hybridizing HLA-A,B,C (2.0  kb) and fl2m (0.95  kb) mRNA bands after autora- 
diography were quantitated by densitometry. The positions of the 18S and 28S ribosomal 
RNA  markers were determined  by the  ethidium  bromide  staining  pattern  of the  gel 
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FIGURE  1.  FACS fluorescence intensity histograms. Placental cells were stained with fluores- 
cein-conjugated MB40.5, which detects a framework determinant on HLA-A,B,C heavy chain 
(left panel) or with biotinated anti-Trop-2,  which reacts with human normal trophoblast and 
choriocarcinoma (right panel) followed by Texas-red-avidin.  Note that fluorescence intensity 
is shown on a logarithmic scale. 
Results 
Single-color  Analysis.  Fig.  1 (left panel) shows fluorescence histograms (on a 
logarithmic scale) of placental cell suspensions stained with a  fluorescein-conju- 
gated anti-HLA-A,B,C framework determinant monoclonal antibody (MB40.5). 
We found three major populations on the basis of the relative amounts of HLA- 
A,B,C antigens on these cells. Interestingly, >70% of the cells have no detectable 
staining with this antibody.  Roughly  10%  have weak but definite staining and 
~8%  have  bright  staining  equal  to  or  greater  than  that  found  with  normal 
peripheral blood lymphocytes (PBL). 
To determine whether the cell isolation procedures used change the density 
of HLA-A,B,C antigens, the effect of the same enzymatic treatment on antigen 
density of normal PBL and SCH cells, an HLA-A,B,C antigen-positive chorio- 
carcinoma  cell  line  (31)  was  tested.  We  found  no  significant  effect  of  this 
treatment  on  antigen  density.  The  cell  surface  antigens  detected  by  other 
monoclonal antibodies described below were also not significantly changed on 
appropriate target cells after this treatment. 
Previously,  we  described  two  monoclonal  antibodies  (Trop-1  and  Trop-2) 
specific for trophoblast antigens on choriocarcinoma cell lines and syncytio- and 
cytotrophoblast in placental sections (20). With these antibodies, we found only 
weak staining of a  majority of suspended placental cells by anti-Trop-1  (Fig. 4), 
but a broad bimodal distribution of staining with anti-Trop-2 (Fig. 1, right panel). 
Two-color Analysis.  Fig. 2 a  depicts a representative staining pattern showing 
five distinct cell populations identified by differences in the correlated fluorescent 
staining intensities for HLA-A,B,C  antigens and Trop-2 antigen on individual 
cells. We designated these five populations A, B, C, D, and E as shown in Fig. 
2a.  Simultaneous Trop-2  and  HLA-A,B,C  staining clearly  resolves the  HLA- KAWATA  ET  AL.  637 
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FIGURE 2.  Representativecontourplotsoftwo-colorimmunofluorescencestainingofplacen- 
tal  cells,  a,  placental  cells  were  stained  with  fluorescein-conjugated  MB40.5  (green)  and 
biotinated  anti-Trop-2  followed by  Texas-red-avidin (red);  b,  unstained  (autofluorescence) 
profile;  c,  stained  with  MB40.5  alone;  d,  stained  with  anti-Trop-2  alone.  Each  contour 
represents a  line connecting points of equal cell frequency. The  contours  were computer- 
generated from correlated fluorescein and Texas-red measurements on 20,000  cells (log-log 
contour displays). 
A,B,C  antigen-negative  population seen  in  Fig.  I  into populations A  and  C. 
Population D, which is HLA-A,B,C weak but Trop-2 negative, is clearly resolved 
from both A and C. Population E is the bright HLA-A,B,C staining population 
in  Fig.  1,  which  we  see  in  Fig.  2,a  and  c  to  be  Trop-2  negative.  To  help 
understand these results, we present in Fig. 2 b, contour plots of red and green 
autofluorescence (fluorescence detected with no added stains) and  in  Fig.  2,c 
and d, contour plots of red and green fluorescence after staining for HLA-A,B,C 
or Trop-2 alone.  Population B  is HLA brightly positive and Trop-2 negative. 
Population B lies in an apparently Trop-2 positive area of the plot in Fig. 2 d, 
but one notices that it lies in exactly the same area in Fig. 2 b (autofluorescence) 
obtained with no fluorescent antibodies; thus it is really Trop-2 negative. In Fig. 
2 c, population B is seen to be spread out and moved to the right by staining with 
fluorescein-conjugated anti-HLA-A,B,C.  In this pattern we also see two other 
small subsets of HLA-A,B,C-positive ceils lacking Trop-2 antigen. Population C 
is a subset of cells negative for both reagents and appears at the origin. 
We present in Table I the fraction of cells from eight normal-term placentas 
lying  within  each  population.  Population  A  is  clearly  the  predominant  cell 
population. The other four subpopulations occur with somewhat variable,  but 
smaller frequencies. 
Fig.  3 shows the size differences indicated by the forward angle light scatter 
profiles. These revealed that the HLA-A,B,C-negative and Trop-2-positive cells 638  HLA  ON  ISOLATED  HUMAN  CYTOTROPHOBLASTS 
TABLE  I 
Cell Populations in Term Placenta* 
A  B  C  D  E 
Cell size  Intermediate/large  Large  Small  Small  Small 
Frequency  74%  8%  2%  6%  2% 
(range)  (66-83)  (2-17)  (1-5)  (1-20)  (0-5) 
Cell surface antigens 
Trop  1  +  .... 
Trop 2  ++  .... 
HLA-A,B,C  -  +++  -  +  ++ 
/32-microglobulin  -  +++  -  +  ++ 
HLA-DR  ....  /+  +/- 
HLe-I  -  -/+  -  +/-  + 
LeuM-1  -  -  -  +/-  - 
Cell origin 
Y-body in male placenta  43%  38%  ND  6%  1% 
HLA-A2 cells [mother, A2(+);  -  0%  ND  <30%  <10% 
fetus, A2(-)] 
Placental alkaline phosphatase  +  ++  ND  +  ND 
activity 
* 8 term placentas. 
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FIGURE  3.  Forward  light  scatter  profiles  of the  five  placental  cell  populations  in  Fig.  2. 
Scatter curves present linear scale (abscissa) vs. relative cell number (ordinate). Dead cells were 
grated out from analyses by propidium iodide staining. 
(A population)  are relatively large as judged  by light  scatter measurement.  In 
contrast,  the C, D, and E cells are small and homogeneous in size. As shown in 
Fig. 3, the B population gives very high light scatter signals, which are confirmed 
to be due to very large  cells by direct  morphological  examination  of sorted B 
cells as described below under Morphology. 
Staining  with  W6/32  and  MB40.5  (anti-HLA-A,B,C  framework  antibodies) 
and two anti-/32m monoclonal antibodies, L368 and BBM. 1, gave identical results 
(data  not  shown).  In  order  to determine  the  amount  of a  series of other  cell A 
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FIGURE 4.  Immunofluorescence staining histograms ofeach placental cell population defined 
in  Fig. 2.  Placental  cells were  co-stained  with fluorescein-conjugated  MB40.5 and  either 
biotinated  anti-Trop-1  or anti-HLA-DR,  or with biotinated  W6/32  and either fluorescein- 
conjugated anti-HLel or anti-LeuM 1 followed by Texas-red-avidin. Placental "A," "B," "D", 
and "E" populations were identified by correlated HLA-A,B,C fluorescence intensity and light 
scatter intensities. FACS curves present  log fluorescence (abscissa) vs. relative cell number 
(ordinate). Solid lines show stained histograms, and dashed lines show red or green autofluo- 
rescence histograms of each population. 
surface antigens on populations A, B, D, and E defined in Fig.  2 a, we identified 
these  populations  by  correlating  HLA-A,B,C  fluorescence  and  light  scatter 
intensities.  The  HLA  intensity  distributions  and  light  scatter  distributions  are 
shown in Figs.  1 and 3, respectively. We then used the computer-stored list mode 
data to determine the distributions of Trop-1, HLA-DR, HLel,  and LeuM1  on 
the  A,  B,  D,  and  E  populations  by computer  gating  with  windows  defined  by 
both  HLA-A,B,C and  scatter  intensities.  These  distributions  are shown  in  Fig. 
4.  Anti-Trop-1  weakly  stains  only  population  A,  consistent  with  the  other 
trophoblast-specific antibody Trop-2, shown in  Fig.  2.  HLA-DR is present on a 
small  and  variable  fraction  of population  B  and  D  cells,  and  on  most  E  cells. 
HLel  (a  pan  leukocyte  antigen  not  found  on  fibroblasts  [18])  is  absent  from 
population  A  but  is on  some  B,  most D, and  most E  cells.  LeuM1  (present  on 
mature granulocytes and monocytes [ 19]) is also absent from population A. Anti- 
LeuM1  stains  only a  small  number  of D  cells.  On  the  basis of these  data  with 640  HLA  ON  ISOLATED  HUMAN CYTOTROPHOBLASTS 
TABLE II 
Placental Alkaline Phosphatase in Placental Populations 
Alkaline phosphatase activity 
Cells  (absorbance at 405 nm)  % PAP 
activity 
Supernatant  Anti-PAP  Anti-LAP 
Placenta populations 
Unfractionated  0.108  0.000  0.128  >96 
A  0.048  0.000  0.047  >97 
B  0.235  0.000  0.232  >98 
D  0.073  0.017  0.074  >77 
Lymphocyte*  0.000  0.000  0.000  0 
BeWo  ~  1.463  0.049  1.506  >97 
LAP  0  0.361  0.430  0.004  1 
* Peripheral blood lymphocytes were isolated from freshly drawn venous blood 
by flotation on a Ficoll/Paque gradient. 
* Gestational choriocarcinoma cell line. 
Purified liver alkaline phosphatase. 
Cell extract was reacted with specific  antibody against placental (PAP) or liver 
alkaline phosphatase (LAP), and the enzyme-antibody complex precipitated. 
The supernatant  was  then  assayed for enzyme activity by measuring the 
hydrolysis of p-nitrophenylphosphate. Activity remaining in the supernatant 
indicates the specific antibody did not react with isoenzyme, and absence of 
enzyme activity in the supernatant indicates that an isoenzyme did react with 
the specific antibody. The percentage of the total activity due to the liver or 
placental isoenzymes  was calculated for each assay. 
anti-HLA-DR,  -HLel  and  -LeuM1,  the  B,  D,  and  E  populations  probably 
contain contaminating blood cells. These data also provide internal controls for 
staining  by these antibodies and confirm the absence of HLA-DR,  HLel,  and 
LeuM 1 on the cells of population A. 
These cell surface phenotypes (summarized in Table I) strongly suggest that 
the  A  population  is  derived  from  trophoblast  lineage  cells,  and  rule  out  the 
possibility  that  this  cell  population  belongs  to  monocyte/macrophage  lineage 
cells. 
Tissue-specific Alkaline Phosphatases of Sorted Cells.  As shown in Table II, PAP 
(and not LAP) was clearly detectable in extracts from the A  population, leading 
us  to  conclude  it  is  of placental  origin,  since  human  placental-type  alkaline 
phosphatase  is  generally  believed  to  be  a  tissue-specific  marker  for  placental 
tissue (32).  Populations B and D  also have PAP activity, suggesting that all or a 
part of these populations is of placental origin. 
Fetal or Maternal Origin of Each Population.  As human placenta is an intricate 
structure made of fetal and maternal  components, careful identification of the 
genetic origin of dispersed cells is extremely important. To determine the origin 
of these  cells,  each  sorted  cell  population  prepared  from  male  placentas  was 
scored by fluorescence microscopy for Y-chromatin-containing cells after stain- 
ing  with  quinacrine  mustard.  Data  in  Table  I  show  43%  and  38%  of cells in 
populations A  and  B, respectively have Y-chromatin,  whereas  much lower fre- 
quencies of D  and  E  cells have  Y-chromatin.  Generally only 30-50%  of male 
cells reveal Y-chromatin (33). Applying a correction based on this underenumer- KAWATA ET  AL.  641 
ation, we estimate that the A  and B populations are almost exclusively of fetal 
origin, while the D and E populations contain cells of fetal and maternal origin. 
In order to confirm the genetic origin of these cell populations by an inde- 
pendent approach, placental cells were obtained from a pregnancy in which the 
baby was typed as HLA-A2-negative on cord blood lymphocytes and the mother 
was typed HLA-A2-positive using her peripheral blood lymphocytes. Then, those 
placental cells were stained with fluoresceinated MB40.5 (anti-HLA-A,B,C anti- 
body, monomorphic determinant) and biotinated PA2.1 (anti-HLA-A2 antibody, 
polymorphic determinant),  which thus can distinguish maternally derived cells 
from fetally derived cells among HLA-A,B,C-positive populations. The absence 
of HLA-A2 antigen on B population cells from a placenta of an HLA-A2 positive 
mother is confirmation of the fetal origin of this population (data shown in Table 
I). In contrast, D and E populations from this placenta have a subset stained by 
PA2.1, indicating the presence of maternal HLA-A2 antigen not shared by the 
fetus; therefore these populations are further divisible into fetaily and maternally 
derived  subpopulations.  These  data  are  also  clearly  consistent  with  the  low 
frequency of Y-chromatin in these populations obtained from male placentas. 
Morphology.  We initially recognized several morphologically distinct cell types 
in the placental  cell  suspensions following trypsin digestion.  Cell  smears were 
prepared  from each  sorted fraction.  Representative cell types in smears from 
sorted populations A and B are illustrated in Fig. 5. Morphological examination 
showed that cell sizes in each population are consistent with the forward scatter 
data described above. The cells in population A were relatively homogeneous in 
appearance and contained large round or irregularly shaped nuclei with a thick 
or thin cytoplasm (Fig. 5,a and b). Most of the cells (1,521/1,526 =  99.7%) were 
uninucleate and the rest had two nuclei. We did not find any typical multinu- 
cleated extremely large syncytiotrophoblasts or blood cells. Plasma membranes 
were occasionally irregular. 
The B population was somewhat heterogenous in morphology: the nuclear to 
cytoplasmic ratios were variable.  Again,  nearly all of the cells (1,301/1,323  = 
98.3%)  were  uninucleate.  It is important to note that large,  typical  Hofbauer 
cells,  characterized  by  strongly  vacuolated  cytoplasms,  were  found  in  the  B 
population (Fig. 5 c) but not in the A population. Hofbauer cells are seen only in 
stromal areas  of placental  tissue sections (34).  Some of the remaining cells in 
population B (see Fig. 5, d and e) are large cells (approximate cell size 25-80/tm) 
that may also be stromal cells. In the D population, we identified a  number of 
polymorphonuclear cells and  some other cells that  we could not classify  (not 
shown). In population E  we saw only typical  lymphocytes and various types of 
blood cells (not shown). 
We  summarize in Table  I  the antigenic phenotypes, genetic origins,  tissue- 
specific  phosphatase  activities,  and  morphological  properties  of  cells  in  the 
placental populations. These observations provide multiple criteria for identify- 
ing  placental  cell  subpopulations  in  suspension.  The  majority  A  population 
consists of homogeneous, trophoblast lineage cells that our evidence indicates 
are cytotrophoblasts. The B cell population appears to consist mainly of stromai 
cells. It is entirely fetal in origin, Trop-1- and Trop-2-negative, consists mostly 642  HLA  ON  ISOLATED HUMAN  CYTOTROPHOBLASTS 
FIGURE 5,  Representative  photographs (stained  with  Giemsa) of cells from populations  A 
and B. Panels a and b show cytotrophoblasts with irregular and smooth membranes,  respec- 
tively, found in population A. Panels c, d, and e show a  Hofbauer cell, a large  and a giant 
stromal cell, respectively,  found in population B. All photos were taken at the same magnifi- 
cation. 
of very large cells including typical Hofbauer cells characteristic  of stromal cells, 
and  also  contains  some  fetal  origin  cells  that  stain  with  HLel.  The  latter  cells 
are presumably fetal macrophage-like cells. 
Populations  C,  D, and  E  contain a  small  proportion  of the  total placental  cell 
suspensions  (maximum  of 10%).  These populations  have (contaminating)  blood KAWATA  ET  AL.  643 
FIGURE 6.  Autoradiography  of  Northern  blot  hybridization  of  human  placental  cyto- 
trophoblast  RNA  with  an  HLA-A,B,C heavy chain  cDNA probe.  Total  cellular  RNA  was 
isolated,  subjected to agarose gel electrophoresis, blotted to a nitrocellulose filter, and hybrid- 
ized with [3,p] labeled HLA-A,B,C cDNA probe as described in Materials and Methods.  12 ~g 
of RNA was loaded in each lane. Lane a, whole placental cells; b, purified cytotrophoblasts; c, 
LCL-721  cells; d, F9 cells; e, Daudi cells. The migration position of the 28S and 18S ribosomal 
RNAs was identified by ethidium bromide staining. 
cells,  mixed  genetic  origins,  and  variable  frequencies  of  reactivity  with  the 
different  monoclonal  antibodies  used.  In order  to obtain  pure  cytotrophoblasts 
from dissociated  placental  cells,  these  small populations  should be removed. 
For the purpose of analyzing  the underlying  molecular  mechanism  accounting 
for the lack of HLA-A,B,C  antigen  on cytotrophoblasts,  4  ×  107 cytotrophoblasts 
(population  A)  were  sorted  as  described  above  and  quickly  frozen  at  -80°C. 
Viability after sorting  procedures  was >95%. 644  HLA  ON  ISOLATED  HUMAN  CYTOTROPHOBLASTS 
Total RNAs extracted from these purified cytotrophoblasts and various control 
cell lines were electrophoresed, blotted onto nitrocellulose filters, and hybridized 
with HLA-A,B,C  or/32m cDNA probes to obtain information about both the 
sizes and the relative amounts of the corresponding mRNA species. The original 
placental cell suspensions before sorting, LCL-721  (lymphoblastoid) and Daudi 
(Burkitt lymphoma) cell lines, were used as controls. We also used the mouse F9 
cell  line as  a  negative control,  since  it  lacks  H-2  and  /32m mRNAs (26),  and 
therefore should not hybridize with the human probes. 
In Fig. 6, the major hybridizing bands (2.0 kb) in lanes a, c, and e represent 
mature HLA mRNA in RNA from unfractionated placental cells, LCL-721 cells 
and  Daudi cells,  respectively.  The fainter larger species presumably represent 
nuclear precursors (unspliced or partially processed). F9 cells (lane d) showed no 
evidence for specific mRNA hybridization even after prolonged exposure. We 
found very faint 2.0-kb bands in RNA extracted from purified cytotrophoblast 
cells (lane b). The relative concentration of HLA-A,B,C mRNA were quantitated 
by  scanning  the  autoradiogram  with  a  densitometer.  By  comparison  of  the 
intensities of the bands obtained with the same amounts of RNA prepared from 
the purified cytotrophoblast fraction or LCL-721,  the former contained ~300 
times less HLA-A,B,C specific mRNA than the latter. We have shown that LCL- 
721  cells have about  the same amount (1.05  times) of HLA-A,B,C  mRNA as 
normal peripheral blood lymphocytes (footnote 2).  These results indicate that 
placental cytotrophoblasts have considerably <1%  of the level of HLA-A,B,C- 
specific mRNA  (both  mature and  precursors)  present  in  LCL-721  or normal 
peripheral lymphocytes. 
In contrast, HLA-A,B,C mRNA is present in whole placental populations (Fig. 
6,  lane  a)  at  ~40%  the  level  of  LCL-721  cells.  This  agrees  well  with  our 
immunofluorescence data described above.  Fig.  6  also shows that Daudi cells, 
which like the cytotrophoblasts lack surface expression of HLA-A,B,C antigens, 
contain high levels of HLA-specific mRNA (lane e) as recently shown (reference 
35, footnote 1). 
The/32-microgiobulin mRNA in purified placental cytotrophoblasts was ana- 
lyzed in a  similar manner (Fig.  7).  The  Northern  blot shows that the labeled 
human fl2m cDNA probe hybridizes to a 0.95-kb mRNA in both cytotrophoblasts 
(lane b) and  LCL-721  cells (lane  c),  although the intensity of the band in the 
cytotrophoblasts was ~ 11% that in LCL-721 cells. Like the cytotrophoblasts, the 
Daudi cells also have clearly detectable levels of/32m mRNA (lane e), despite the 
lack of cell surface expression. As expected, the/32m probe did not hybridize to 
any mRNA inF9 cells (lane d). 
Discussion 
We have developed a  method to identify and separate cell populations from 
human  placental  cell  suspensions  using  immunofluorescence staining,  FACS 
analysis, and sorting. The heterogeneity of suspended placental cells with respect 
to size,  amounts of HLA-A,B,C  and  Trop antigens,  autofluorescence, genetic 
Kawata, M., K. Sizer, S. Sekiya, J. R. Parnes, and L, A. Herzenberg. 1984. Differential expression 
of HLA-A,B,C antigens on choriocarcinoma cell lines: limited by mRNA for HLA heavy chain, not 
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FIGURE 7.  Autoradiography  of  Northern  blot  hybridization  of  human  placental  cyto- 
trophoblast  RNA with a/52-microglobulin cDNA probe.  Procedures were identical to those 
described in  Fig.  I.  Lane a,  whole placental cells; b, purified cytotrophohlasts;  c,  LCL-721 
cells; d, F0 cells; e, Daudi cells. 
origin, and the presence of blood cells and dead cells has previously hampered 
the preparation of pure subpopulations of placental cells. However, the addition 
of two-color correlated fluorescence, log amplification, and PI staining methods 
(22) to previous FACS methodology (36) is particularly helpful for resolving and 
sorting  such  mixed  cell  populations.  We  found  that  the  most  abundant  cell 
population,  A  (66-83%  of placental  cell  suspension),  consists  of fairly  pure 
cytotrophoblasts. These cells express the cell surface antigens Trop-1 and Trop- 
2, are HLA-DR-, HLel-, and LeuMl-negative, PAP activity-positive, Y-chro- 
matin-positive (using male placentas), and are large mononuclear cells. Further- 
more, we have obtained phenotypically similar cells from suspensions ofchorionic 646  HLA ON  ISOLATED HUMAN CYTOTROPHOBLASTS 
membrane that contains a  layer of cytotrophoblasts (M.  K., unpublished obser- 
vation). This supports the identification of placental A cells as cytotrophoblasts. 
In confirmation of studies by others (8-10), we have shown that cytotrophoblasts 
at term have undetectable levels of HLA-A,B,C antigens on their surface. 
Mammalian  reproduction  occurs  under  unique  biological  circumstances in 
which allogeneic and semiallogeneic cells take part in the processes of fertiliza- 
tion, implantation, and development of the fetus in utero. Although it has been 
suggested that a number of different mechanisms are involved in the protection 
of the fetus from a  maternal alloreactive immune response (7),  the absence of 
HLA-A,B,C antigens could certainly act as a fundamental barrier against mater- 
nal transplantation immunity. 
A  variety of explanations  have  been  postulated  to  explain  the  absence  of 
detectable transplantation antigens on trophoblast cells:  (a) enzymatic removal 
of the determinants during cell preparation;  this is strongly argued against by 
our findings that SCH line cells and normal blood lymphocytes show no loss of 
HLA-A,B,C  antigens  by  identical  treatments  and  that  other  placental  cells 
obtained by our procedure retain  HLA-A,B,C antigens.  Of course we cannot 
rule out a slight loss of HLA antigens by preferential sensitivity of these antigens 
on cytotrophoblasts to trypsin or enzymes released by placenta during trypsini- 
zation;  (b)  masking  of the  antigenic  determinants  in  some  way by  overlying 
membrane-bound mucoprotein or other molecules (37); (c) immunological mask- 
ing of the determinants by preformed maternal alloantibody (this appears un- 
likely because we have been unable to detect human immunoglobulins on the 
surface of the cytotrophoblast population using double staining with anti-HLA- 
A,B,C and anti-human immunoglobulins, unpublished data); (d) lack of transcrip- 
tion  of HLA-A,B,C and/or /32-microglobulin genes; (e) decreased HLA-A,B,C 
and/or/32m mRNA stability; (f) posttranscriptional processing deficiencies for 
HLA-A,B,C and/or/3e-microglobulin mRNAs; (g) defects in the assembly of the 
heterodimer, its transport to or insertion into the plasma membrane. 
To better define the molecular mechanism for the lack of trophoblast HLA- 
A,B,C antigen expression, we have examined the levels of mRNA corresponding 
to HLA antigens and/32-microglobulin, respectively, in a purified population of 
cytotrophoblast  cells.  Using  cDNA  hybridization  probes  and  Northern  blot 
analysis, we found extremely low levels of HLA-A,B,C mRNA in the purified 
cytotrophoblast cells (300-fold lower than in LCL-721  or normal lymphocytes). 
These  results  are  consistent  with  regulation  at  the  level  of transcription  or, 
conceivably, stability of HLA-A,B,C mRNA. 
In contrast to the results for the HLA-A,B,C mRNA, we found the level of 
/32-microglobulin mRNA in cytotrophoblasts to be only ninefold lower than in 
the lymphoid cell  line  LCL-721.  These results imply that /32m  mRNA is  not 
limiting the expression of surface HLA-A,B,C molecules in these cells, and that 
/32m and HLA-A,B,C synthesis are differentially regulated. Together with our 
recent experiments  2 showing that the amounts of HLA-A,B,C antigens on the 
surface of choriocarcinoma cell lines are proportional to the amounts of HLA- 
A,B,C mRNA and not to the amount of/32m mRNA, the present data strongly 
support the idea that the amount of HLA-A,B,C anitgens on the trophoblast cell 
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the case with  Daudi where/32m  translation  limits  the amount of surface HLA 
expression (39-41). 
HLA-A,B,C  antigens  are  expressed  on  almost  all  normal  tissues  (42).  The 
results reported here are of biological interest because they demonstrate a tissue- 
specific limitation of HLA-A,B,C gene expression in a normal cell population, as 
well as a  differential  regulation  of mRNA levels for HLA-A,B,C antigens  and 
~82-microgiobulin. 
Goodfeliow et al. (9) reported that B2m could be found in the cytosol fraction 
of syncytiotrophoblast  membrane  preparations  without  significant  amounts  of 
HLA-A,B,C antigens.  Syncytiotrophoblast cells are  generally  recognized  to be 
differentiated derivatives of cytotrophoblasts (38), and in direct contact with the 
maternal circulation. Based upon these results and our current findings, it seems 
likely that  the absence of HLA-A,B,C antigens  on  syncytiotrophoblasts is also 
controlled  by the  level  of HLA-A,B,C  mRNA  and  not  by the  level  of/~2m 
mRNA. 
It  is  of considerable  importance  to  follow the  changes  in  the  regulation  of 
HLA  and  other  alloantigenic  molecules  in  the  early  stages  of placenta  and 
extraembryonic  membrane  development.  Using  mouse  teratocarcinoma  stem 
cell lines, a widely used model system for studies of normal early embryogenesis, 
one of us (43) and others (44) reported that  H-2 and ~2m mRNAs in undiffer- 
entiated teratocarcinoma  cell lines are absent or appear  100 times less than  in 
differentiated  teratocarcinoma  cells, and  that  both  mRNAs appeared  simulta- 
neously along with differentiation  induced by retinoic acid.  Trophoblastic cells 
differentiate  early  in  development  as  the  first  specialized  cell  lineage  from  a 
normal embryonal cell mass, and continuously localize between maternal  tissue 
and the developing fetus. Although virtually nothing is known about the molec- 
ular events in early human embryogenesis, selective transcriptional repression of 
HLA-A,B,C  heavy  chain  molecules,  which  are  involved  in  the  specificity for 
recognition  of "self" and  "not  self,"  might  be a  unique  regulatory  system for 
trophoblastic lineage cells.  Recent findings indicate that  the DNA of the HLA- 
A,B,C genes of at least one trophoblastic cell line can not transfect for expression 
in a DNA mediated gene transfer system into mouse fibroblastsP This is in sharp 
contrast with DNA from any other cell or tissue source examined. 4 
It is well established that antibodies directed against paternally inherited  fetal 
HLA-A,B,C antigens are found in the sera of multiparous women (45), and that 
these antibodies are also elutable from full-term placentas (46). These observa- 
tions suggest that the placenta acts not only as a potential source of ailoantigenic 
stimulation,  but also as an immunoabsorbent with alloantigenic specificity. The 
differential  expression  of HLA-A,B,C antigens  on  placental  A  and  B  cells,  as 
shown in  this  study,  suggests that  placental  cells expressing paternally  derived 
HLA-A,B,C antigens are B population, stromal cells. It agrees with the finding 
of HLA-A,B,C on stroma in immunohistological studies by Faulk et al. (8). Thus, 
B cells as well as circulating fetal cells detectable by anti-paternal  HLA antigens 
3 Alberti, S., and L. A. Herzenberg. Unpublished material. 
4 Hsu, C., P. Kavathas, and L. A. Herzenberg. 1984. Expression of cell-surface differentiation 
antigens on mouse L cells transfected with whole genomic DNA from non-expressing as well as 
expressing cells or tissues. Submitted for publication. 648  HLA ON  ISOLATED HUMAN CYTOTROPHOBLASTS 
(47) may be a source ofalloantigen responsible for inducing alloantibodies during 
pregnancy. The stromal cells are also good candidates for absorbers ofanti-HLA 
antibodies known to be present in placenta. 
We carefully examined placental cell suspensions for multinucleated cells and 
did  not  observe  any.  This  is  consistent  with  observations  by  Carr  (48)  that 
syncytial trophoblasts are broken readily by trypsinization. As cytotrophoblasts 
generally are recognized to be the precursors of syncytiotrophoblasts, it would 
be interesting to examine their formation from cytotrophoblasts in vitro.  The 
availability of pure  viable cytotrophoblasts provides a  good starting point  for 
such studies and also facilitates immunological, endocrinological, and molecular 
studies  of human  trophoblasts.  This  method  may also  provide  the  means  to 
identify and collect cytotrophoblasts by transcervical chorion biopsy or possibly 
in  maternal  peripheral  blood  (49,  50)  for  direct  biochemical  and  molecular 
diagnoses at early prenatal stages. 
Summary 
Human placental cell suspensions prepared by trypsin digestion were analyzed 
with several monoclonal antibodies on a  multiparameter fluorescence-activated 
cell sorter (FACS). Five distinct cell populations were isolated on the basis of size 
and quantitative differences in the coordinate expression of cell surface antigens 
detected by monoclonal antibodies against an HLA-A,B,C monomorphic deter- 
minant (MB40.5) and against human trophoblasts (anti-Trop-2). By FACS anal- 
ysis and after sorting we clearly identified the major cell population  as  cyto- 
trophoblasts based on several independent criteria, including presence of troph- 
oblast-specific surface antigens, Trop-1, and Trop-2; absence of all HLA class I, 
class II, and/32-microglobulin 032m) antigens; absence of the pan-leucocyte and 
monocyte antigens, HLel and LeuM 1, respectively; presence of Y-chromatin in 
a male placenta; presence of placental and not liver alkaline phosphatase; and a 
large,  mononuclear  morphology.  These  procedures  provide  a  reproducible 
method for obtaining  highly purified human cytotrophoblast populations  for 
further studies. 
We measured by molecular hybridization (RNA or Northern blots) the HLA- 
A,B,C and 132m mRNA in  total  RNA extracted from sorted cytotrophoblasts. 
We find that normal human cytotrophoblasts have extremely small amounts of 
HLA-A,B,C mRNA: ~300 times less than that in the lymphoid cell line LCL- 
721  or  normal  lymphocytes. In  contrast,  they have  -11%  the  level  of 132m 
mRNA  present  in  LCL-721  cells.  Thus,  HLA-A,B,C  antigen  expression  on 
human cytotrophoblasts is limited by the level of HLA heavy chain mRNA. 
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